NCT00653068

Clinical Trial Information

Trial Number: NCT00653068 (ClinicalTrials.gov)

Disease Type:

CNS Neoplasm (Primary Tumor) - Embryonal Tumors

Trial Title:

Treatment of Atypical Teratoid/Rhabdoid Tumors (AT/RT) of the Central Nervous System with Surgery, Intensive Chemotherapy, and 3-D Conformal Radiation

Study ID:

ACNS0333

Images are available?:

Is this a NCI-MATCH Trial?:

Datasets Linked to Trial

Title	Description
NCT00653068-D3	There are 3 data submissions (NCT00653068-D1, -D2, and -D3) associated with PMID 32105509. This dataset, NCT00653068-D3, provides specific data for the outcome, event-free survival (EFS), of Figure 3B, the primary analytic comparison: ACNS0333 patients < 36 months of age verses the historical control.
NCT00653068-D2	There are 3 data submissions (NCT00653068-D1, -D2, and -D3) associated with PMID 32105509. This dataset, NCT00653068-D2, provides specific incidence of grade 4 or higher adverse events that occurred in 5% or more of patients in at least one phase of therapy. This dataset is necessary to construct Table A2 (Treatment-Associated Toxicity).
NCT00653068-D1	There are 3 data submissions (NCT00653068-D1, -D2, and -D3) associated with PMID 32105509. This dataset, NCT00653068-D1, provides information on the flow of patients enrolled in ACNS0333 through therapy shown in the CONSORT diagram in Figure 2, the variable categories of Table 3 and Table 4, and other variables to define patient attributes and outcomes as reported in the manuscript. There is one row for each patient enrolled.

Accessibility | Disclaimer | FOIA | HHS Vulnerability Disclosure | Privacy & Security

U.S. Department of Health and Human Services | National Institutes of Health | National Cancer Institute | USA.gov

NIH…Turning Discovery Into Health^®